Effect of chronic hydroxychloroquine use on COVID-19 risk in patients with rheumatoid arthritis and systemic lupus erythematosus: a multicenter retrospective cohort

OBJECTIVE: Hydroxychloroquine (HCQ) has been used during the coronavirus disease 2019 (COVID-19) pandemic because of its reported anti-viral activity. This study examined the association of chronic HCQ use with the incidence and complications of COVID-19. METHODS: This retrospective cohort study inc...

Descripción completa

Detalles Bibliográficos
Autores principales: Walbi, Ismail A., Albarqi, Hassan A., Alghanim, Nayef Saleh, Albadi, Marzooq Abdullah, Al Maimouni, Hesham Mohammed, Alkahtani, Saad Ahmed, Alshabi, Ali Mohamed, Alali, Amer S., Alqahtani, Faleh, Al-Najjar, Amal Hassan, Hazzazi, Mohammad A, Alanazi, Deemah S, Sabei, Abdulrahman Abdulaziz, Alsaweed, Omer S, Alajra, Rahaf K, Alqhtani, Hussain
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Retrospective Clinical Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8998490/
https://www.ncbi.nlm.nih.gov/pubmed/35387504
http://dx.doi.org/10.1177/03000605221090363

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8998490/
https://www.ncbi.nlm.nih.gov/pubmed/35387504
http://dx.doi.org/10.1177/03000605221090363

Ejemplares similares